2,6-dimethyl-1,4-benzoquinone has been researched along with thymoquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremer, PT; Hixon, MS; Janda, KD | 1 |
| Horrocks, P; Johnson-Ajinwo, OR; Li, WW; Mbye, H; Richardson, A; Ullah, I | 1 |
2 other study(ies) available for 2,6-dimethyl-1,4-benzoquinone and thymoquinone
| Article | Year |
|---|---|
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
Topics: Benzoquinones; Binding Sites; Botulinum Toxins, Type A; Drug Design; Kinetics; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2014 |
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
Topics: Antimalarials; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2018 |